Rosenberg Matthew Hamilton

Position in REGN — Regeneron Pharmaceuticals, Inc.

CIK 1812103 GRAND JUNCTION, CO

Position in REGN

as of Jun 30, 2026 · filed Jul 17, 2026 Compact

Position Value

$37,412

-$8,946 QoQ

Shares Held

0.0% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.03%

of 13F equity value

Holder Rank

#1,144

of 1,322 holders

Holding Since

Dec 2021

19 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Rosenberg Matthew Hamilton holds $136,109 across 3 Biotechnology names. REGN ranks #2 (27.5% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	184	$91,398
2	REGN	Regeneron Pharmaceuticals, Inc. This page	60	$37,412
3	SMMT	Summit Therapeutics Inc.	501	$7,299

19 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$37,412	60	0.0%	Shares	Sole	2026-07-17
2026-03-31	$46,358	60	0.0%	Shares	Sole	2026-04-07
2025-12-31	$46,312	60	0.0%	Shares	Sole	2026-01-05
2025-09-30	$33,736	60	0.0%	Shares	Sole	2025-11-10
2025-06-30	$31,500	60	0.0%	Shares	Sole	2025-07-28
2025-03-31	$38,053	60	0.0%	Shares	Sole	2025-04-28
2024-12-31	$42,739	60	-9.1%	Shares	Sole	2025-01-14
2024-09-30	$69,381	66	0.0%	Shares	Sole	2024-10-28
2024-06-30	$69,367	66	0.0%	Shares	Sole	2024-07-26
2024-03-31	$63,524	66	0.0%	Shares	Sole	2024-04-22
2023-12-31	$57,967	66	+10.0%	Shares	Sole	2024-01-16
2023-09-30	$49,377	60	0.0%	Shares	Sole	2023-10-11
2023-06-30	$43,112	60	0.0%	Shares	Sole	2023-07-26
2023-03-31	$49,300	60	0.0%	Shares	Sole	2023-04-17
2022-12-31	$43,289	60	0.0%	Shares	Sole	2023-01-19
2022-09-30	$41,332	60	0.0%	Shares	Sole	2022-10-21
2022-06-30	$35,467	60	0.0%	Shares	Sole	2022-07-15
2022-03-31	$41,905	60	0.0%	Shares	Sole	2022-04-14
2021-12-31	$37,891	60	—	Shares	Sole	2022-01-20
No filing history on record for this holder in this stock.